8 Things to Know About Urolithin A and Whether It Actually Addresses Menopause Muscle Loss
When the muscle loss started feeling different from just 'getting older,' that was the moment worth paying attention to. There's something uniquely demoralizing about doing the same workouts you've always done and watching your strength quietly disappear anyway — and it took a while to understand that estrogen was doing far more in muscle tissue than anyone ever mentioned.
Learn more about Rose →Muscle Loss in Perimenopause Isn't Just About Inactivity — Estrogen Has a Direct Role in Muscle Maintenance
Estrogen receptors are present in skeletal muscle tissue, and estrogen actively supports muscle protein synthesis, reduces inflammation within muscle fibers, and helps regulate satellite cells — the stem cells responsible for muscle repair and growth. When estrogen declines during perimenopause, this protective scaffolding weakens, making muscle loss faster and recovery from exercise slower than activity levels alone would explain. This is why the standard advice to 'just lift weights' can feel frustratingly insufficient without understanding the hormonal context underneath it.
Mitophagy Is the Cellular Process Urolithin A Is Claimed to Activate — and It Matters for Muscle Quality
Mitophagy is a selective form of autophagy in which the body identifies and clears out damaged or dysfunctional mitochondria, allowing healthier mitochondria to take their place. Mitochondria are the energy-producing structures inside muscle cells, and when they accumulate damage over time — which accelerates with age and hormonal change — muscle function, endurance, and recovery all decline. Urolithin A is proposed to stimulate this cleanup process, essentially improving the quality of the mitochondrial pool inside muscle cells rather than simply adding more mitochondria.
Urolithin A Is Not Directly Found in Food — the Body Has to Produce It, and Not Everyone Can
Urolithin A is a postbiotic — it is produced when gut bacteria metabolize ellagitannins, polyphenols found in pomegranates, walnuts, and certain berries. The conversion requires specific gut microbiome composition, and research estimates that somewhere between 30 and 40 percent of people lack the bacterial strains needed to produce meaningful amounts of urolithin A from food alone. This is a critical piece of context often missing from food-first messaging: dietary pomegranate consumption does not reliably translate to urolithin A activity in most people.
The Most Cited Human Trial Showed Real Improvements in Muscle Endurance — But the Participants Were Older, Not Specifically Perimenopausal Women
A 2022 randomized controlled trial published in JAMA Network Open — one of the most rigorous urolithin A studies to date — found that supplementation improved muscle endurance and certain mitochondrial biomarkers in sedentary middle-aged and older adults over four months. The results were statistically significant, but the study population was broadly aged 40–65 and was not designed to isolate effects in women with declining estrogen specifically. Extrapolating those findings to perimenopause muscle loss is reasonable as a hypothesis, but it is not yet the same as evidence targeted to that population.
Estrogen Decline and Mitochondrial Dysfunction Appear to Be Linked — Which Is Where the Urolithin A Hypothesis Gets Interesting
Emerging research suggests that estrogen itself plays a role in maintaining mitochondrial function in muscle tissue, partly through its influence on mitochondrial biogenesis and antioxidant defenses within cells. When estrogen drops, mitochondrial efficiency in muscle appears to decline, potentially accelerating the accumulation of the dysfunctional mitochondria that mitophagy is meant to clear. This creates a plausible biological rationale for why a mitophagy activator like urolithin A might be particularly relevant during perimenopause — though this specific connection has not yet been tested in dedicated clinical trials.
Urolithin A Has a Solid Safety Profile in Human Trials — That Part Is Not in Dispute
Multiple Phase 1 and Phase 2 clinical trials have found urolithin A supplementation to be well-tolerated at doses ranging from 250mg to 2000mg per day, with no significant adverse effects reported in healthy adults. This is genuinely reassuring, particularly given how many supplements enter wellness markets before any meaningful human safety data exists. The safety question and the efficacy question are separate, though — tolerability does not confirm that the supplement does what is claimed, and both pieces of evidence deserve independent scrutiny.
The Research on Urolithin A and Strength — as Opposed to Endurance — Is Still Thin
Most urolithin A trials have measured outcomes like hand grip endurance, walking performance, and mitochondrial biomarkers rather than maximal strength or muscle mass directly. For perimenopausal women, where the concern is often about sarcopenia — the progressive loss of muscle mass — this distinction matters. Endurance improvements are meaningful, but they don't necessarily translate to the preservation of muscle tissue volume, which requires different physiological mechanisms and different outcome measures to assess properly.
Urolithin A Is Not a Replacement for Resistance Training or Hormone Therapy — but It May Work Better Alongside Them
The most evidence-supported interventions for menopause-related muscle loss remain progressive resistance training and, where appropriate, hormone replacement therapy — both of which address the estrogen-muscle connection more directly and with stronger clinical backing. Urolithin A's proposed role in clearing dysfunctional mitochondria could theoretically support the cellular environment in which exercise and hormonal support do their work, making it a potentially useful adjunct rather than a standalone strategy. Women considering it deserve to understand that hierarchy clearly before making any decisions.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.